AI in Healthcare — Africa Risk Dashboard

AI in Healthcare — Africa Risk Dashboard

Contextual and risk analysis of clinical-AI deployments across nine African countries, benchmarked against the United States. Explore the risk tier filter and country search below.

9 countries16 AI models6 risk dimensionsUS benchmark
African countries studied
9
Total AI models deployed
16
US benchmark: 84
Declared hospitals
64
US benchmark: 4,200
Users reached (known)
22,012,579
Declared funding
$790.2M
High / Critical risk countries
8 / 9

1 · Executive summary

  • Across the 9 countries studied, 16 clinical-AI models are deployed — an order of magnitude below the US benchmark of 84 models and ~4,200 hospitals.
  • Declared healthcare-AI funding sums to $790.2M, but the largest single item (Babylon Health, ~$650M+) is foreign-funded rather than domestic.
  • 4 countries are at Critical risk (ETHIOPIA, KENYA, MAURITIUS, GHANA) and 4 at High risk (NIGERIA, SOUTH AFRICA, EGYPT, MOROCCO) — driven mainly by data-transparency gaps and narrow deployment footprints.
  • RWANDA has the lowest composite risk (66.4/100) but still trails the US benchmark on every axis.
  • Clinical-domain coverage is concentrated in radiology, triage and documentation; high-burden areas such as maternal–fetal medicine, pathology and emergency triage remain largely uncovered.

2 · Contextual landscape

Where are clinical-AI models deployed, how many hospitals use them and how much funding supports them?

Models per countryFunding per country
Hospitals vs usersClinical domain coverageBenchmark gap

3 · Risk measurement

Six normalised risk dimensions capture data transparency, deployment scale, funding sustainability, clinical-domain gaps, population equity and the aggregate benchmark gap to the US. Higher values = higher risk.

Overall risk
Risk heatmapRisk tier distribution
Radar plot
Risk-dimension glossary
  • Data Transparency — Share of core metrics that are undocumented or unclear for a country's deployed AI models. Opaque reporting blocks audit, clinical validation and post-market surveillance.
  • Deployment Scale — Risk that models are deployed in too few hospitals to be clinically validated or generalisable across patient populations.
  • Funding Sustainability — Risk that AI models lack the funding per model needed for maintenance, retraining on drifted data and regulatory compliance.
  • Clinical Domain Gap — Distance to a mature market's (US) coverage of 18 clinical domains. Narrow domain coverage leaves high-burden conditions unaddressed.
  • Population Equity — Risk that too few patients benefit from clinical AI, creating access gaps between those served and those excluded.
  • Benchmark Gap — Composite gap between the country and the US benchmark on models, hospitals and domains — the headline inequity indicator.

4 · Country summary table

CountryModelsHospitalsDomainsTransparencyRiskTier
MAURITIUS110.0%98.7Critical
GHANA110.0%98.7Critical
KENYA11133.3%93.1Critical
ETHIOPIA22333.3%90.6Critical
MOROCCO22120.0%83.8High
SOUTH AFRICA340.0%77.6High
NIGERIA338333.3%73.8High
EGYPT22333.3%73.0High
RWANDA1266.7%66.4Moderate

5 · Country-by-country context

Filter by risk tier or search for a country.

NIGERIA High Risk 73.8

3 indigenous models; strongest population reach (11k+) but small per-model funding (~$900k avg). Triage, preventive care and clinical documentation focus.

Models: 3Hospitals: 38Domains: 3Users: 11,000Funding: $2.7M

SOUTH AFRICA High Risk 77.6

Radiology-heavy; Qure.ai alone reports 10M+ patients, but hospital counts are undocumented — hidden footprint risk.

Models: 3Hospitals: unclearDomains: 4Users: 10,000,000Funding: $67.0M

EGYPT High Risk 73.0

Dominated by Vezeeta's telehealth platform (10M users, 78 cities); Baheya breast-cancer AI is narrowly deployed (2 hospitals).

Models: 2Hospitals: 2Domains: 3Users: 10,000,000Funding: $70.5M

ETHIOPIA Critical Risk 90.6

Early-stage ecosystem; AXIR-CX data mainly from research (n=1,579), generalisability risk is high.

Models: 2Hospitals: 2Domains: 3Users: 1,579Funding: unclear

MOROCCO High Risk 83.8

Mostly foreign-sourced tech (Da Vinci) without local funding trail; endocrinology + surgery, narrow domain coverage.

Models: 2Hospitals: 21Domains: 2Users: unclearFunding: unclear

KENYA Critical Risk 93.1

Single AMR-stewardship model in one hospital (Narok) — critical scale risk despite a high-impact clinical use case.

Models: 1Hospitals: 1Domains: 1Users: unclearFunding: unclear

RWANDA Moderate Risk 66.4

Relies on Babylon Health (foreign funded, $650-675M+) — sustainability tied to an external commercial roadmap.

Models: 1Hospitals: unclearDomains: 2Users: 2,000,000Funding: $650.0M

MAURITIUS Critical Risk 98.7

DRRIYA only; no documented hospitals, users or funding — near-total transparency gap.

Models: 1Hospitals: unclearDomains: 1Users: unclearFunding: unclear

GHANA Critical Risk 98.7

minoHealth radiology AI system; almost every contextual field undocumented — critical transparency risk.

Models: 1Hospitals: unclearDomains: 1Users: unclearFunding: unclear
Generated on April 16, 2026 · Source: Mapping.xlsx · AI-in-Healthcare Analysis v1.0